↓ Skip to main content

Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab

Overview of attention for article published in Frontiers in oncology, April 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Body mass index and baseline platelet count as predictive factors in Merkel cell carcinoma patients treated with avelumab
Published in
Frontiers in oncology, April 2023
DOI 10.3389/fonc.2023.1141500
Pubmed ID
Authors

Lorena Incorvaia, Alessandra Dimino, Laura Algeri, Chiara Brando, Luigi Magrin, Ida De Luca, Erika Pedone, Alessandro Perez, Roberta Sciacchitano, Annalisa Bonasera, Tancredi Didier Bazan Russo, Federica Li Pomi, Marta Peri, Valerio Gristina, Antonio Galvano, Dario Giuffrida, Ivan Fazio, Francesca Toia, Adriana Cordova, Ada Maria Florena, Antonio Giordano, Viviana Bazan, Antonio Russo, Giuseppe Badalamenti

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 2 29%
Researcher 1 14%
Lecturer 1 14%
Unknown 3 43%
Readers by discipline Count As %
Environmental Science 1 14%
Biochemistry, Genetics and Molecular Biology 1 14%
Social Sciences 1 14%
Unknown 4 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2023.
All research outputs
#23,663,708
of 26,343,220 outputs
Outputs from Frontiers in oncology
#16,691
of 22,976 outputs
Outputs of similar age
#365,002
of 423,670 outputs
Outputs of similar age from Frontiers in oncology
#788
of 1,222 outputs
Altmetric has tracked 26,343,220 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,976 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,670 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,222 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.